192 related articles for article (PubMed ID: 24646079)
1. Radiation lethality potentiation in total body irradiated mice by a commonly prescribed proton pump inhibitor, Pantoprazole sodium.
Biju PG; Gubrij I; Garg S; Gupta PK; Hauer-Jensen M; Burnett AF
Int J Radiat Biol; 2014 Jul; 90(7):554-9. PubMed ID: 24646079
[TBL] [Abstract][Full Text] [Related]
2. Pantoprazole: a proton pump inhibitor.
Moreira Dias L
Clin Drug Investig; 2009; 29 Suppl 2():3-12. PubMed ID: 19938880
[TBL] [Abstract][Full Text] [Related]
3. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
Devault KR
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole.
Gouraud A; Vochelle V; Descotes J; Vial T
Clin Drug Investig; 2010; 30(8):559-63. PubMed ID: 20586518
[TBL] [Abstract][Full Text] [Related]
5. Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.
Jiao HW; Sun LN; Li YQ; Yu L; Zhang HW; Wang MF; Yu LY; Yuan ZQ; Xie LJ; Chen J; Meng L; Zhang XH; Wang YQ
Eur J Clin Pharmacol; 2018 Mar; 74(3):257-265. PubMed ID: 29167917
[TBL] [Abstract][Full Text] [Related]
6. A possible involvement of Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the proton pump inhibitor pantoprazole against indomethacin-induced gastric damage in rats.
Lee HJ; Han YM; Kim EH; Kim YJ; Hahm KB
BMC Gastroenterol; 2012 Oct; 12():143. PubMed ID: 23066659
[TBL] [Abstract][Full Text] [Related]
7. Effect of proton pump inhibitor pantoprazole on growth and morphology of oral Lactobacillus strains.
Altman KW; Chhaya V; Hammer ND; Pavlova S; Vesper BJ; Tao L; Radosevich JA
Laryngoscope; 2008 Apr; 118(4):599-604. PubMed ID: 18176340
[TBL] [Abstract][Full Text] [Related]
8. Pantoprazole increases cell viability and function of primary human osteoblasts in vitro.
Prause M; Seeliger C; Unger M; van Griensven M; Haug AT
Injury; 2014 Aug; 45(8):1156-64. PubMed ID: 24893920
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
10. Pantoprazole, a proton-pump inhibitor, impairs human sperm motility and capacitation in vitro.
Escoffier J; Arnaud B; Kaba M; Hograindleur JP; Le Blévec E; Martinez G; Stévant I; Ray PF; Arnoult C; Nef S
Andrology; 2020 Nov; 8(6):1795-1804. PubMed ID: 32609951
[TBL] [Abstract][Full Text] [Related]
11. Pantoprazole, a proton pump inhibitor, delays fracture healing in mice.
Histing T; Stenger D; Scheuer C; Metzger W; Garcia P; Holstein JH; Klein M; Pohlemann T; Menger MD
Calcif Tissue Int; 2012 Jun; 90(6):507-14. PubMed ID: 22527206
[TBL] [Abstract][Full Text] [Related]
12. Effects of pantoprazole on ulcer healing delay associated with NSAID treatment.
Fornai M; Colucci R; Antonioli L; Ghisu N; Tuccori M; Blandizzi C; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):305-13. PubMed ID: 18853145
[TBL] [Abstract][Full Text] [Related]
13. Anaphylaxis to Pantoprazole: A Case Report and Prerequisite for Vigilant Prescribing Practises for Proton Pump Inhibitors.
James J; Rani J; Sathyanarayanan V; Begum A; Fayaz SH
Curr Drug Saf; 2022; 17(1):78-80. PubMed ID: 34323194
[TBL] [Abstract][Full Text] [Related]
14. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.
Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D;
Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
16. Pantoprazole decreases cell viability and function of human osteoclasts in vitro.
Prause M; Seeliger C; Unger M; Rosado Balmayor E; van Griensven M; Haug AT
Mediators Inflamm; 2015; 2015():413097. PubMed ID: 25873758
[TBL] [Abstract][Full Text] [Related]
17. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
[TBL] [Abstract][Full Text] [Related]
18. Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms.
Schillinger W; Teucher N; Sossalla S; Kettlewell S; Werner C; Raddatz D; Elgner A; Tenderich G; Pieske B; Ramadori G; Schöndube FA; Kögler H; Kockskämper J; Maier LS; Schwörer H; Smith GL; Hasenfuss G
Circulation; 2007 Jul; 116(1):57-66. PubMed ID: 17576869
[TBL] [Abstract][Full Text] [Related]
19. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
Cheer SM; Prakash A; Faulds D; Lamb HM
Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers.
Tutuian R; Katz PO; Bochenek W; Castell DO
Aliment Pharmacol Ther; 2002 Apr; 16(4):829-36. PubMed ID: 11929403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
